Semaglutide prevents, rather than causes, diabetes, and is a popular treatment for those diagnosed with type 2 diabetes.
Novel TKI regorafenib also augments the effects of ICI therapy against HCC (Xie et al., 2023)
Asymptomatic : In asymptomatic patients with risk factors (see Table 1: Patient Risk Factors Associated with B 12 Deficiency above) consider supplementation in lieu of testing
instead, it undergoes proteolytic degradation similar to endogenous proteins, which contributes to its low drug-drug interaction potential via hepatic pathways
Tuan-Mahmood T-M, McCrudden MTC, Torrisi BM, McAlister E, Garland MJ, Singh TRR, et al
J Cancer Res Clin Oncol 147:10771087